Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., … Lieberman, J. A. (2008). Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia Research.

Daumit, G. L., D. C. Goff, J. M. Meyer, V. G. Davis, H. A. Nasrallah, J. P. McEvoy, R. Rosenheck, et al. “Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.” Schizophrenia Research, 2008.

Daumit GL, Goff DC, Meyer JM, Davis VG, Nasrallah HA, McEvoy JP, et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia Research. 2008;

Daumit, G. L., et al. “Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.” Schizophrenia Research, 2008.

Daumit GL, Goff DC, Meyer JM, Davis VG, Nasrallah HA, McEvoy JP, Rosenheck R, Davis SM, Hsiao JK, Stroup TS, Lieberman JA. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia Research. 2008;